The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen)

Competition Authority, Malta

Article précédent The French Competition Authority rejects request by a mobile telephone equipment hosting company to lift competition commitments due to likelihood of abuse of dominant position (TDF) Article suivant The Canadian Competition Tribunal dismisses the Competition Authority’s challenge over a merger between two of Canada’s four biggest broadband providers (Rogers / Shaw)

30 Dec 2022

The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen)

KEYWORDS

Reference

Maltese Competition Authority, Gland Pharma / Phixen, Press release, 30 December 2022

Notification of Concentration* In terms of regulation 5(4) of the Control of Concentrations Regulations, 2002 published in Legal Notice 294 of 2002, the Director

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

Version PDF

Auteur

Malta Competition Authority
Malta Competition and Consumer Affairs Authority (Ħamrun)

Malte 14 contributions 847 visites

Citation

Malta Competition Authority, The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen), 30 décembre 2022, e-Competitions December 2022, Art. N° 110491

Visites 55

Tous les numéros

Latest News issue
Tous les News issues
Latest Special issue
Tous les Special issues